Oregovomab

Oregovomab
Oregovomab ?
Monoclonal antibody
Type Whole antibody
Source Mouse
Target CA125
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 213327-37-8 N
ATC code None
KEGG D05269 YesY
Chemical data
Formula  ?
Mol. mass ca. 150 kDa
 N(what is this?)  (verify)

Oregovomab (marketed under the trade name OvaRex) is a mouse monoclonal antibody it binds to the antigen CA125, a carbohydrate antigen. It is designed for the treatment of ovarian cancer.[1]

This drug was developed by AltaRex Corp.

References

  1. ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Oregovomab, American Medical Association.